Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study
| Autor: | Xu, Min, Shu, Jinhui, Qian, Shenxian, Guo, Jingming, Gong, Yuping, Huang, Ruibin, Wang, Shuye, Zhou, Zeping, Yuan, Guolin, Huang, Meijuan, Lin, Li-E, Lou, Shifeng, Song, Yanping, Liu, Qingchi, Zhou, Hu, Mei, Heng, Hu, Yu |
|---|---|
| Zdroj: | In The Lancet Regional Health - Western Pacific June 2024 47 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|